Medication info
Famotidine Tablet (Famotidine)

Famotidine Tablet (Famotidine)

Prescription medicationTabletOral · Intramuscular injection · Intravenous injection
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Seohung Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 1,000 tablets/bottle
Approval status
Active

MFDS item code 201908164 · Approved 2019.11.29 · Insurance code 679601270

Summary

Main use
Treatment of acid-related disorders; preanesthetic medication; improvement of gastric mucosal lesions and upper gastrointestinal bleeding
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: In adults, administer famotidine orally at a dose of 20 mg twice daily (after breakfast and dinner or at bedtime) or 40 mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and changed to oral administration once oral administration is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10 mg twice daily (after breakfast and dinner or at bedtime) or 20 mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20 mg of famotidine in 20 ml of normal saline injection or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; change to oral administration once oral administration is possible. For pre-anesthetic medication, dissolve 20 mg in 1-1.5 ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20 ml of normal saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or under refrigeration. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Seohung Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders; preanesthetic medication; improvement of gastric mucosal lesions and upper gastrointestinal bleeding

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal redness
  • gastric mucosal swelling
View approved original text

This medication is used to treat upper gastrointestinal bleeding caused by gastric and duodenal ulcers, anastomotic ulcers, and peptic ulcers as well as acute stress ulcers. It is also effective in treating bleeding due to hemorrhagic gastritis and managing gastroesophageal reflux disease. It helps improve gastric mucosal lesions (erosions, bleeding, redness, swelling) due to conditions associated with excessive gastric acid secretion, such as Zollinger-Ellison syndrome, as well as acute exacerbations of acute and chronic gastritis. In injectable form, it is also used prior to anesthesia, and overall, it is widely used for the treatment of upper gastrointestinal diseases and to protect the gastric mucosa. This medication is used to improve and treat various symptoms of gastrointestinal disorders.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: In adults, administer famotidine orally at a dose of 20 mg twice daily (after breakfast and dinner or at bedtime) or 40 mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation, and changed to oral administration once oral administration is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10 mg twice daily (after breakfast and dinner or at bedtime) or 20 mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20 mg of famotidine in 20 ml of normal saline injection or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; change to oral administration once oral administration is possible. For pre-anesthetic medication, dissolve 20 mg in 1-1.5 ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20 ml of normal saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or under refrigeration. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used by those who have had allergic reactions to this drug's ingredients or similar medications. Furthermore, this medication contains lactose, so it should not be taken by individuals with a genetic condition that prevents lactose digestion. Those with drug allergies, poor kidney function, heart disease, weak liver function, and the elderly should use this medication cautiously. During the course of this medication, serious allergic reactions, blood abnormalities, skin rashes, liver dysfunction, muscle issues, cardiac arrhythmias, consciousness disorders, kidney problems, pneumonia, and other side effects may occur; if any abnormal symptoms appear, consult a doctor immediately. Additionally, while this medication dissolves in the mouth, it should be swallowed with water or saliva as it is not absorbed through the oral mucosa. Regular blood tests, liver function tests, and kidney function tests should be conducted, and if therapeutic effects are absent, switching to another medication is recommended. Caution must be taken if patients on dialysis use this medication along with phosphate binders, as the effectiveness of the drug may be reduced. This medication may alter drug concentrations when taken with certain antifungal agents or specific anticancer drugs, so it is essential to inform a doctor or pharmacist if other medications are being taken. Elderly individuals may need reduced dosages or longer intervals between doses due to decreased kidney function, leading to prolonged presence of the drug in the body. Women who are pregnant or may become pregnant should only use this medication when its benefits outweigh risks, and breastfeeding mothers are advised to discontinue breastfeeding as this medication may be passed through breast milk. Safety has not been adequately established for use in children, and thus it is not recommended. Finally, this medication may mask symptoms of gastric cancer; therefore, it should only be used after confirming that it is not gastric cancer.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • respiratory distress
  • generalized flushing
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 75 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • Reiter's syndrome
  • hepatic dysfunction
  • jaundice
  • increased AST
  • increased ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • generalized convulsions
  • interstitial nephritis
  • acute renal failure
  • rash
  • erythema
  • urticaria
  • facial edema
  • leukopenia
  • increased eosinophils
  • constipation
  • diarrhea
  • soft stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • increased ALP
  • elevated total bilirubin
  • increased LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • heaviness
  • reversible confusional state
  • depression
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • increased CK
  • altered taste
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing this way will help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 1,000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.